Can we produce reproducible, QC‑released batches of A 5:1 blend of Sphenocentrum jollyanum (acute neurovascular trigger) and Eurycoma longifolia (chronic endocrine/stress modulator) for male vitality meeting ≥80% HPLC similarity across three independent runs using our SOPs?
This is the first demonstration case not the end goal.